ME02086B - Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin - Google Patents

Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin

Info

Publication number
ME02086B
ME02086B MEP-2013-336A MEP33613A ME02086B ME 02086 B ME02086 B ME 02086B ME P33613 A MEP33613 A ME P33613A ME 02086 B ME02086 B ME 02086B
Authority
ME
Montenegro
Prior art keywords
integrin
beta
alpha
compositions
treating
Prior art date
Application number
MEP-2013-336A
Other languages
German (de)
French (fr)
Unknown language (me)
Inventor
Dean Sheppard
Amha Atakilit
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Priority claimed from EP05763460.2A external-priority patent/EP1734996B1/en
Publication of ME02086B publication Critical patent/ME02086B/en

Links

MEP-2013-336A 2004-04-02 2005-03-30 Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin ME02086B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55917504P 2004-04-02 2004-04-02
EP05763460.2A EP1734996B1 (en) 2004-04-02 2005-03-30 Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
PCT/US2005/011222 WO2005094391A2 (en) 2004-04-02 2005-03-30 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH αVβ5 INTEGRIN

Publications (1)

Publication Number Publication Date
ME02086B true ME02086B (en) 2014-02-28

Family

ID=49078157

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-336A ME02086B (en) 2004-04-02 2005-03-30 Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin

Country Status (2)

Country Link
ME (1) ME02086B (en)
SI (1) SI1734996T1 (en)

Also Published As

Publication number Publication date
SI1734996T1 (en) 2013-08-30

Similar Documents

Publication Publication Date Title
HK1216080A1 (en) Compositions and methods for treating or preventing oxalate-related disease
HRP20130782T1 (en) Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
EP1962873A4 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
PL1908779T3 (en) Thymosin beta 4 derivatives and use thereof
PL1920065T3 (en) Anti-alpha v beta 6 antibodies and uses thereof
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
EP1742640A4 (en) Methods and compositions for treating diseases and conditions associated with mitochondrial function
EP1827389A4 (en) Sustained-release nanoparticle compositions and methods for using the same
EP1737482A4 (en) Compositions and methods for treating diseases
EP1680009A4 (en) Compositions and methods for diagnosing and treating mental disorders
EP1589996A4 (en) Anti-integrin alpha beta 3 antibody formulat ions and uses thereof
EP1668024A4 (en) Oligonucleotide compositions and methods for treating disease including inflammatory conditions
EP1978034A4 (en) Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
ZA200707407B (en) Composition for preventing plant diseases and method for preventing the diseases
EP1755537A4 (en) Methods and compositions for preventing or treating periodontal diseases
EP1512415A4 (en) Decoy composition for treating and preventing inflammatory disease
IL178598A0 (en) Skin-protecting alkalinity-controlling composition and the use thereof
EP1583966A4 (en) Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061,17662,1468,12282, 6350, 9035,1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123,12788,17729, 65552,1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32
EP1807067A4 (en) Sphingosine kinase activator and skin disease treating agent comprising the same
HK1075272A1 (en) Dye composition and the use thereof
ME02086B (en) Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
EP1850827A4 (en) Composition for treating and preventing periodontal disease and method of use
EP1804795A4 (en) Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
EP1829860A4 (en) 9,10-secopregnane derivative and medicine
PT1965816T (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease